HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Prescription patterns and costs of antihypertensive drugs in two outpatient clinics: Zürich (Switzerland) and Münster (FRG), 1975-1985.

Abstract
In the present study the prescription patterns and cost of antihypertensive drugs in two outpatient clinics located in two different countries (Zürich, Switzerland, and Münster, FRG), were analyzed from 1975 till 1985 by using representative random samples of hypertensive outpatients. Throughout the observed period the leading positions were held by diuretics and beta-blockers, whereas central sympatholytics and ganglion blockers nearly disappeared. A rapid increase in the use of calcium antagonists occurred within the last 2 analyzed years. Drugs in fixed combination containing reserpin showed a constant decrease during the observed period, whereas beta-blocker-containing combination drugs increased in both clinics. The comparison between the two clinics revealed only minor differences in the prescription pattern of the various known classes of antihypertensive drugs. However, marked differences were observed within given classes between the preferred products. Both in Zürich and Münster the mean annual drug cost per patient doubled from 1975 to 1985. Especially during the last few years these changes took place with a remarkable rapidity, obviously the result of a more intense promotion of new antihypertensive drugs.
AuthorsM Knorr, J Frielingsdorf, F Graf, H Vetter, W Vetter
JournalNephron (Nephron) Vol. 47 Suppl 1 Pg. 120-4 ( 1987) ISSN: 1660-8151 [Print] SWITZERLAND
PMID2892142 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics
  • Sympatholytics
  • Vasodilator Agents
  • Captopril
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Antihypertensive Agents (therapeutic use)
  • Calcium Channel Blockers (therapeutic use)
  • Captopril (therapeutic use)
  • Cost-Benefit Analysis
  • Diuretics (therapeutic use)
  • Drug Prescriptions (economics)
  • Drug Therapy, Combination
  • Female
  • Germany, West
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Switzerland
  • Sympatholytics (therapeutic use)
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: